Hims & Hers unveiled a once-a-day weight-loss pill this week, calling it an alternative for needle-averse customers and those looking for smaller doses. It was essentially a cheaper copy of the Wegovy pill that the pharmaceutical company, Novo Nordisk , released earlier this year. About 48 hours later, the telehealth company said it would stop selling it. "Since launching the compounded semaglutide pill on our platform, we've had constructive conversations with stakeholders across the industry,"